Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
20.8%
% of CNCR's 72 holdings also in IDNA
33.3%
% of IDNA's 49 holdings also in CNCR
Overlap by Weight
Sector Drift (CNCR minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CNCR |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 2.0% | 6.7% | 2.0% |
|
ARCELLX, INC. | 1.7% | 3.9% | 1.7% |
|
SPRINGWORKS THERAPEUTICS, INC. | 1.7% | 3.0% | 1.7% |
|
REVOLUTION MEDICINES, INC. | 1.6% | 4.7% | 1.6% |
 |
BIONTECH SE SPONSORED ADR | 1.5% | 5.0% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to IDNA
|
RECURSION PHARMACEUTICALS, INC CLASS | 3.3% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | 2.4% |
|
MONTE ROSA THERAPEUTICS, INC. | 2.1% |
|
JANUX THERAPEUTICS, INC. | 1.9% |
|
REPLIMUNE GROUP, INC. | 1.9% |
|
BRISTOL-MYERS SQUIBB CO | 1.8% |
|
MERSANA THERAPEUTICS, INC. | 1.7% |
|
SCHRODINGER, INC. | 1.7% |
|
ENLIVEN THERAPEUTICS, INC. | 1.6% |
|
ZYMEWORKS INC. | 1.6% |
CNCR Underweight Relative to IDNA
|
GILEAD SCIENCES INC | -5.9% |
|
INCYTE CORP | -4.9% |
 |
BEIGENE, LTD. | -4.8% |
|
EXELIXIS INC | -4.7% |
 |
ROCHE HOLDING LTD | -4.4% |
|
SAREPTA THERAPEUTICS INC | -4.2% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
 |
SANOFI-AVENTIS | -4.0% |
|
BIONTECH SE SPONSORED ADR | -3.5% |
 |
GSK PLC | -3.4% |